{"title":"在拉丁美洲对付蛇咬伤的综合办法的必要性:本国科学和技术研究的相关性","authors":"J. Gutiérrez, J. A. Pereañez","doi":"10.17533/UDEA.VITAE.V23N2A01","DOIUrl":null,"url":null,"abstract":"Snakebite envenomings constitute a serious public health problem on a global level, especially in Africa, Asia and Latin America [1, 2]. In our Latin American region, it is estimated that at least 70,000 snakebite cases occur every year, although the actual number is likely to be higher [3]. This pathology is one of the so-called ‘neglected tropical diseases’, i.e. a group of diseases that affect primarily poor people in poor settings and, therefore, does not receive the necessary attention from research agencies, pharmaceutical companies, and health authorities. Consequently, it has been described as a ‘disease of poverty’ [3, 4]. In our continent it largely affects impoverished populations living in rural areas, including indigenous groups [3].","PeriodicalId":23515,"journal":{"name":"Vitae-revista De La Facultad De Quimica Farmaceutica","volume":"41 1","pages":"103-105"},"PeriodicalIF":0.0000,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"The need for an integrated approach in confronting snakebite envenoming in Latin America: the relevance of endogenous scientific and technological research\",\"authors\":\"J. Gutiérrez, J. A. Pereañez\",\"doi\":\"10.17533/UDEA.VITAE.V23N2A01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Snakebite envenomings constitute a serious public health problem on a global level, especially in Africa, Asia and Latin America [1, 2]. In our Latin American region, it is estimated that at least 70,000 snakebite cases occur every year, although the actual number is likely to be higher [3]. This pathology is one of the so-called ‘neglected tropical diseases’, i.e. a group of diseases that affect primarily poor people in poor settings and, therefore, does not receive the necessary attention from research agencies, pharmaceutical companies, and health authorities. Consequently, it has been described as a ‘disease of poverty’ [3, 4]. In our continent it largely affects impoverished populations living in rural areas, including indigenous groups [3].\",\"PeriodicalId\":23515,\"journal\":{\"name\":\"Vitae-revista De La Facultad De Quimica Farmaceutica\",\"volume\":\"41 1\",\"pages\":\"103-105\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vitae-revista De La Facultad De Quimica Farmaceutica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17533/UDEA.VITAE.V23N2A01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vitae-revista De La Facultad De Quimica Farmaceutica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17533/UDEA.VITAE.V23N2A01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The need for an integrated approach in confronting snakebite envenoming in Latin America: the relevance of endogenous scientific and technological research
Snakebite envenomings constitute a serious public health problem on a global level, especially in Africa, Asia and Latin America [1, 2]. In our Latin American region, it is estimated that at least 70,000 snakebite cases occur every year, although the actual number is likely to be higher [3]. This pathology is one of the so-called ‘neglected tropical diseases’, i.e. a group of diseases that affect primarily poor people in poor settings and, therefore, does not receive the necessary attention from research agencies, pharmaceutical companies, and health authorities. Consequently, it has been described as a ‘disease of poverty’ [3, 4]. In our continent it largely affects impoverished populations living in rural areas, including indigenous groups [3].